VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
tofacitinib우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42251788

Restoration of Treg function and polarization of M2 macrophages by tofacitinib to alleviate sarcoidosis through the mediation of the JAK3/STAT5 pathway.

Restoration of Treg function and polarization of M2 macrophages by tofacitinib to alleviate sarcoidosis through the mediation of the JAK3/STAT5 pathway.

저자
Ting Sheng, Shiyun Zhang, Di Ma, Yiyang Jie, Yong Wang, Jingjing Ding
저널
Molecular immunology
공개일
2026 Aug
연구 유형
기타
DOI
10.1016/j.molimm.2026.05.013

문헌 요약

Sarcoidosis is a multisystem granulomatous syndrome with a wide range of clinical features. Tofacitinib, a JAK inhibitor, may become a new treatment for sarcoidosis. The study aimed to elucidate how tofacitinib modulates immune responses and reduces granuloma formation in SodA-induced sarcoidosis. To evaluate the effects of tofacitinib on granuloma format…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기